[1]
|
Qian, Y., Wang, L., Yu, L.L. and Huang, W.M. (2021) Pregnancy- and Lactation-Associated Osteoporosis with Verte-bral Fractures: A Systematic Review. BMC Musculoskeletal Disorders, 22, Article No. 926.
https://doi.org/10.1186/s12891-021-04776-7
|
[2]
|
Kyvernitakis, I., Reuter, T.C., Hellmeyer, L., Hars, O. and Hadji, P. (2018) Subsequent Fracture Risk of Women with Pregnancy and Lactation-Associated Osteoporosis after a Median of 6 Years of Follow-Up. Osteoporosis International, 29, 135-142. https://doi.org/10.1007/s00198-017-4239-1
|
[3]
|
Hong, N., Kim, J.E., Lee, S.J., Kim, S.H. and Rhee, Y.M. (2018) Changes in Bone Mineral Density and Bone Turnover Markers during Treatment with Teriparatide in Pregnancy- and Lactation-Associated Osteoporosis. Clinical Endocrinology, 88, 652-658. https://doi.org/10.1111/cen.13557
|
[4]
|
Kovacs, C.S. (2016) Maternal Mineral and Bone Metabolism during Preg-nancy, Lactation, and Post-Weaning Recovery. Physiological Reviews, 96, 449-547. https://doi.org/10.1152/physrev.00027.2015
|
[5]
|
Sowers, M., Corton, G., Shapiro, B., et al. (1993) Changes in Bone Density with Lactation. JAMA, 269, 3130-3135.
https://doi.org/10.1001/jama.1993.03500240074029
|
[6]
|
Sanz-Salvador, L., García-Pérez, M., Tarín, J.J., et al. (2015) Bone Metabolic Changes during Pregnancy: A Period of Vulnerability to Osteoporosis and Fracture. European Journal of Endocrinology, 172, R53-R65.
https://doi.org/10.1530/EJE-14-0424
|
[7]
|
Breasail, M.Ó., Prentice, A. and Ward, K. (2020) Pregnancy-Related Bone Mineral and Microarchitecture Changes in Women Aged 30 to 45 Years. Journal of Bone and Mineral Research, 35, 1253-1262.
https://doi.org/10.1002/jbmr.3998
|
[8]
|
Butscheidt, S., Delsmann, A., Rolvien, T., et al. (2018) Mutational Analysis Uncovers Monogenic Bone Disorders in Women with Pregnancy-Associated Osteoporosis: Three Novel Mutations in LRP5, COL1A1, and COL1A2. Osteoporosis International, 29, 1643-1651. https://doi.org/10.1007/s00198-018-4499-4
|
[9]
|
Luther, J., Yorgan, T.A., Rolvien, T., et al. (2018) Wnt1 is an Lrp5-Independent Bone-Anabolic Wnt Ligand. Science Translational Medicine, 10, eaau7137. https://doi.org/10.1126/scitranslmed.aau7137
|
[10]
|
Phillips, A.J., Ostlere, S.J. and Smith, R. (2000) Pregnan-cy-Associated Osteoporosis: Does the Skeleton Recover? Osteoporosis International, 11, 449-454. https://doi.org/10.1007/s001980070113
|
[11]
|
Ferrari, S., Bianchi, M.L., Eisman, J.A., et al. (2012) Osteoporosis in Young Adults: Pathophysiology, Diagnosis, and Management. Osteoporosis International, 23, 2735-2748. https://doi.org/10.1007/s00198-012-2030-x
|
[12]
|
Hadji, P., Boekhoff, J., Hahn, M., et al. (2017) Pregnan-cy-Associated Osteoporosis: A Case-Control Study. Osteoporosis International, 28, 1393-1399. https://doi.org/10.1007/s00198-016-3897-8
|
[13]
|
Kovacs, C.S. and Ralston, S.H. (2015) Presentation and Man-agement of Osteoporosis Presenting in Association with Pregnancy or Lactation. Osteoporosis International, 26, 2223-2241. https://doi.org/10.1007/s00198-015-3149-3
|
[14]
|
Kok, C. and Sambrook, P.N. (2009) Secondary Os-teoporosis in Patients with an Osteoporotic Fracture. Best Practice & Research Clinical Rheumatology, 23, 769-779. https://doi.org/10.1016/j.berh.2009.09.006
|
[15]
|
Schmidt, T., Schmidt, C., Schmidt, F.N., et al. (2018) Disease Du-ration and Stage Influence Bone Microstructure in Patients with Primary Biliary Cholangitis. Journal of Bone and Miner-al Research, 33, 1011-1019.
https://doi.org/10.1002/jbmr.3410
|
[16]
|
Della Martina, M., Biasioli, A., Vascotto, L., et al. (2010) Bone Ultraso-nometry Measurements during Pregnancy. Archives of Gynecology and Obstetrics, 281, 401-407. https://doi.org/10.1007/s00404-009-1133-x
|
[17]
|
Møller, U.K., Við Streym, S., Mosekilde, L. and Rejnmark, L. (2012) Changes in Bone Mineral Density and Body Composition during Pregnancy and Postpartum. A Controlled Co-hort Study. Osteoporosis International, 23, 1213-1223.
https://doi.org/10.1007/s00198-011-1654-6
|
[18]
|
Sowers, M. (1996) Pregnancy and Lactation as Risk Factors for Subsequent Bone Loss and Osteoporosis. Journal of Bone and Mineral Research, 11, 1052-1060. https://doi.org/10.1002/jbmr.5650110803
|
[19]
|
Hardcastle, S.A. (2022) Pregnancy and Lactation Associated Oste-oporosis. Calcified Tissue International, 110, 531-545.
https://doi.org/10.1007/s00223-021-00815-6
|
[20]
|
Sokal, A., Elefant, E., Leturcq, T., et al. (2019) Pregnancy and Newborn Outcomes after Exposure to Bisphosphonates: A Case-Control Study. Osteoporosis International, 30, 221-229. https://doi.org/10.1007/s00198-018-4672-9
|
[21]
|
Li, L.J., Zhang, J., Gao, P., et al. (2018) Clinical Characteristics and Bisphosphonates Treatment of Rare Pregnancy- and Lactation-Associated Osteoporosis. Clinical Rheumatology, 37, 3141-3150.
https://doi.org/10.1007/s10067-018-4185-0
|
[22]
|
Laroche, M., Talibart, M., Cormier, C., et al. (2017) Pregnan-cy-Related Fractures: A Retrospective Study of a French Cohort of 52 Patients and Review of the Literature. Osteoporo-sis International, 28, 3135-3142.
https://doi.org/10.1007/s00198-017-4165-2
|
[23]
|
Burt, L.A., Liang, Z., Sajobi, T.T., Hanley, D.A. and Boyd, S.K. (2016) Sex- and Site-Specific Normative Data Curves for HR-pQCT. Journal of Bone and Mineral Research, 31, 2041-2047. https://doi.org/10.1002/jbmr.2873
|
[24]
|
Vahle, J.L., Long, G.G., Sandusky, G., et al. (2004) Bone Ne-oplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose. Toxicologic Pathology, 32, 426-438.
https://doi.org/10.1080/01926230490462138
|
[25]
|
Iolascon, G., Moretti, A., Toro, G., Gimigliano, F., Liguori, S. and Paoletta, M. (2020) Pharmacological Therapy of Osteoporosis: What’s New? Clinical Interventions in Aging, 15, 485-491. https://doi.org/10.2147/CIA.S242038
|
[26]
|
Ijuin, A., Yoshikata, H., Asano, R., et al. (2017) Teriparatide and Denosumab Treatment for Pregnancy and Lactation-Associated Osteoporosis with Multiple Vertebral Fractures: A Case Study. Taiwanese Journal of Obstetrics and Gynecology, 56, 863-866. https://doi.org/10.1016/j.tjog.2017.10.028
|
[27]
|
Black, D.M., Bilezikian, J.P., Ensrud, K.E., et al. (2005) One Year of Alendronate after One Year of Parathyroid Hormone (1-84) for Osteoporosis. The New England Journal of Medicine, 353, 555-565.
https://doi.org/10.1056/NEJMoa050336
|
[28]
|
Lindsay, R., Scheele, W.H., Neer, R., et al. (2004) Sustained Verte-bral Fracture Risk Reduction after Withdrawal of Teriparatide in Postmenopausal Women with Osteoporosis. Archives of Internal Medicine, 164, 2024-2030.
https://doi.org/10.1001/archinte.164.18.2024
|
[29]
|
Lee, S., Hong, N., Kim, K.J., et al. (2021) Bone Density after Teriparatide Discontinuation with or without Antiresorptive Therapy in Pregnancy- and Lactation-Associated Osteoporo-sis. Calcified Tissue International, 109, 544-553.
https://doi.org/10.1007/s00223-021-00869-6
|